Screener
AnaptysBio, Inc. ANAB Interest Income
Interest Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeOther.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total operating expenses | 60,193 | 55,310 |
| Loss from operations | (34,637) | (27,539) |
| Other income (expense), net: | ||
| Interest income | 2,653 | 4,413 |
| Non-cash interest expense for the sale of future royalties | (20,859) | (18,061) |
| Other (expense) income, net | (1) | 1,902 |
| Total other expense, net | (18,207) | (11,746) |
| Loss before income taxes | (52,844) | (39,285) |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s interest income?
- AnaptysBio, Inc. (ANAB) reported interest income of $2.65M in Q1 2026.
- How has AnaptysBio, Inc.'s interest income changed year-over-year?
- AnaptysBio, Inc.'s interest income decreased by 39.9% year-over-year, from $4.41M to $2.65M.
- What is the long-term trend for AnaptysBio, Inc.'s interest income?
- Over 4 years (2021 to 2025), AnaptysBio, Inc.'s interest income has grown at a 136.6% compound annual growth rate (CAGR), from $431K to $13.5M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about AnaptysBio, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude